Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.

Rie HoriiHitoshi TsudaShinobu MasudaHironobu SugitaKenichi TogashiShinji OhnoFutoshi Akiyama

Published in: Breast cancer (Tokyo, Japan) (2020)

The performance of 30-9 is equivalent to that of MIB-1 in Ki67 assessment of breast cancer. The image analysis system can substitute for or support visual counting by a pathologist.

Keyphrases

neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
lymph node
breast cancer risk